This study is in progress, not accepting new patients
Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma
Summary
- Eligibility
- for people ages up to 21 years (full criteria)
- Location
- at UCSD UCSF
- Dates
- study startedestimated completion
- Principal Investigator
- by Sabine Mueller, MD, PhD, MAS (ucsf)
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at University of California Health
- Sabine Mueller, MD, PhD, MAS (ucsf)
Professor, Neurology, School of Medicine
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of California, San Francisco
- ID
- NCT03739372
- Study Type
- Interventional
- Participants
- Expecting 44 study participants
- Last Updated